Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia.

导出 LinkOut

翻译打印收藏纠错

作者： Nan,Zhang ^[1] ; Xiaoyan,Liu ^[1] ; Jinxian,Wu ^[1] ; Xinqi,Li ^[1] ; Qian,Wang ^[1] ; Guopeng,Chen ^[1] ; Linlu,Ma ^[1] ; Sanyun,Wu ^[1] ; Fuling,Zhou ^[2]

作者单位： Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China. ^[1] Department of Hematology, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuhan 430072, China. ^[2]

关键词 ICAM2 acute myeloid leukemia proteomics risk stratification

DOI 10.1177/20406207221132346

PMID 36324489

发布时间 2022-11-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Therapeutic advances in hematology

2022年13卷

20406207221132346页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Serum proteomics screening intercellular adhesion molecule-2 improves intermediate-risk stratification in acute myeloid leukemia.

Therapeutic advances in hematology

相似文献

Therapeutic advances in hematology

相关期刊

检索历史清除